Details
- Pasqal announced a strategic collaboration with True Nexus to apply neutral-atom quantum computing to model protein functionality in alternative proteins, targeting gelatin, texture, and behavior in food systems.
- Pasqal, a French quantum computing firm planning to go public via SPAC merger with Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ) at $2B valuation; True Nexus, Saudi-based computational intelligence company focused on programmable protein functionality.
- The partnership develops the first fully vectorized, dynamic 3D model of protein gelation, integrating protein extraction parameters, molecular structure, processing conditions, and end-use requirements using Pasqal's quantum processors for superior precision over classical computing.
- Addresses long-standing industry challenge of matching animal-protein functionality after 20+ years of trial-and-error; Pasqal founded in 2019 with 275+ employees, clients like CMA CGM and Thales.
- No direct competitors in quantum-food protein modeling found; aligns with quantum applications in biotech, potentially accelerating sustainable food innovation amid growing alternative protein market.
Impact
This collaboration tackles a core barrier in alternative proteins, enabling precise modeling to boost adoption rates in a $15B+ market. It positions quantum computing in industrial biotech, potentially steering R&D toward hybrid quantum-classical tools and attracting funding to neutral-atom tech over 12-24 months as food sustainability demands rise.
